|
Topic:
Glioblastoma Multiforme: Current Medical
Treatments and Future Directions
About Speaker:
Olivier Rixe, MD, PhD, is an
internationally recognized medical
oncologist in the field of developmental
therapeutics and brain tumors. Dr. Rixe
has received numerous awards, which
include the Merit Order (Ordre National
du Merite) for cancer research from the
President of France, Jacques Chirac.
While working as an oncologist, he has
had nearly 300 publications. He has held
a senior position in academia for the
past 25 years where he has conducted
clinical trials in patients with
resistant tumors, including many
translational studies, testing new
therapeutic strategies with
chemotherapy, gene therapy, targeted
therapy and immunotherapy. He served as
a senior investigator in the Phase 1
Unit at Gustave Roussy Institute in
Villejuif, France. Dr. Rixe was
appointed Professor of Medical Oncology
in 2003 at Pierre and Marie Curie
University (Paris 6). In 2008, Dr. Rixe
joined the Medicine Oncology Branch at
the NCI in Bethesda, MD as a staff
clinician. In 2009, Dr. Rixe came to the
University of Cincinnati (UC) as a
Professor of Medicine and the John and
Gladys Strauss Chair in cancer research
and assumed the position of both
Director of the Experimental
Therapeutics Program and Research
Director of the UC Brain Tumor Center.
More recently, he was the co-director of
the brain tumor program with Dr Omar
Chohan at the NCI-designated cancer
center at University of New Mexico.
He is currently Vice President at
Daiichi Sankyo, NJ for early drug
development.
 |
